Flex Pharma (FLKS) Discloses John McCabe Promoted to CFO
Tweet Send to a Friend
Flex Pharma (NASDAQ: FLKS) disclosed that on December 13, 2016, the Compensation Committee of the Board of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
